Cite
MLA Citation
Colin D Weekes et al.. “Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?.” Lancet oncology, vol. 19, no. 5, 2018, pp. 591–592. http://access.bl.uk/ark:/81055/vdc_100060491107.0x000015
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Colin D Weekes et al.. “Tivantinib for advanced hepatocellular carcinoma: is MET still a viable target?.” Lancet oncology, vol. 19, no. 5, 2018, pp. 591–592. http://access.bl.uk/ark:/81055/vdc_100060491107.0x000015